Skip to main content

Table 1 Demographic and Clinical Patient Characteristics (n = 30)

From: Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication

Age, mean ± SD, years

37.5 ± 9.7

Sex, n (%), female/male

13(43.3)/17(56.7)

Duration of illness, mean ± SD, years

PANSS score at baseline, mean ± SD

8.7 ± 6.7

 Total score

59.7 ± 16.5

  Positive symptoms

12.1 ± 5.1

  Negative symptoms

17.0 ± 7.1

  General psychopathology

30.6 ± 8.1

GAF score at baseline, mean ± SD

56.7 ± 16.4

  1. PANSS = Positive and Negative Syndrome Scale; GAF = Global Assessment of Functioning Scale